Life Technologies Corp
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY12 | FY11 | FY10 | FY09 | FY08 | |
|---|---|---|---|---|---|
| Revenue | $939.1M | $895.9M | $3.59B | $3.28B | $1.62B |
| Operating income | $665.2M | $647.8M | $612.4M | $385.9M | $167.0M |
| Net income | $132.6M | $93.7M | $378.3M | $144.6M | $5.7M |
| Total assets | $8.64B | $9.19B | $9.49B | $9.12B | — |
| Total liabilities | $3.98B | $4.59B | $5.05B | $5.09B | — |
| Equity | $4.65B | $4.60B | $4.43B | $4.03B | $3.46B |
| EPS (diluted) | $0.72 | $0.50 | $1.99 | $0.80 | $0.05 |
| Shares out. | 178.3M | 180.0M | 190.6M | 181.4M | 103.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2012- Operating margin
- 70.8%
- Net margin
- 14.1%
- Return on equity
- 2.9%
- Return on assets
- 1.5%
- Return on capital (ROCE)
- 8.9%
- Liabilities / assets
- 46.1%
- Debt / equity
- 0.86×
- Book value / share
- $26.10
- Revenue growth (YoY)
- 4.8%
- Net income growth (YoY)
- 41.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2012- Altman Z″ (distress)
- 2.58grey zone
- Accruals / assets
- −7.5%clean
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 warning● 5 good- Altman Z″ in the grey zone
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureFeb 4, 2014
- Results of operations · Regulation FD disclosureNov 5, 2013
- Shareholder voteAug 21, 2013
- Results of operations · Regulation FD disclosureJul 31, 2013
- Other material eventJul 22, 2013
- Other material eventJun 26, 2013
- Other material eventJun 7, 2013
- Results of operations · Regulation FD disclosureMay 2, 2013
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/ALIFE EXITFeb 11, 2015
- SC 13G/AFeb 14, 2014
- SC 13G/AFeb 14, 2014
- 15-12GFeb 14, 2014
- SC 13G/AFeb 14, 2014
- SC 13G/AFeb 12, 2014
- EFFECTFeb 4, 2014
- 15-15DFeb 4, 2014
- 4PRIMARY DOCUMENTFeb 4, 2014
- 4PRIMARY DOCUMENTFeb 4, 2014
- 4PRIMARY DOCUMENTFeb 4, 2014
- 4PRIMARY DOCUMENTFeb 4, 2014
- 4PRIMARY DOCUMENTFeb 4, 2014
- 4PRIMARY DOCUMENTFeb 4, 2014
- 4PRIMARY DOCUMENTFeb 4, 2014
Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.